Flow-mediated dilation by ultrasound imaging
通过超声成像进行血流介导的扩张
基本信息
- 批准号:7140252
- 负责人:
- 金额:$ 19.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-01 至 2008-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Endothelial dysfunction, an early marker of atherosclerosis, is a significant cardiovascular risk factor that is implicated for many diseases, including hypertension and diabetes. There is therefore a major effort to develop a noninvasive test for endothelial dysfunction. Flow-mediated dilation of the brachial artery measured by ultrasound imaging offers this possibility, and its use has been demonstrated in various clinical studies. Despite encouraging results, the technique is not recommended for routine clinical use, mainly because of its low sensitivity and large coefficient of variation. This application is designed to overcome these limits . We propose the use of compound imaging to enhance image quality; cross-sectional imaging to improve sensitivity and coefficient of variations, and automated boundary detection for continuous monitoring of vasodilation during ultrasound examination. We tested these concepts is flow phantoms and showed that sensitivity can be improved by as much as 150 times over the conventional method. We also demonstrated the technique could be used to image human subjects. The results were published in a recent article. In this R21 application, we are seeking support for a feasibility study in human subjects. Flow-mediated dilation will be measured in a small number (N = 60) of healthy volunteers . The goal is to demonstrate that ultrasound imaging of brachial artery cross-section using compounding and automated boundary detection have higher sensitivity and reproducibility than the conventional approach using longitudinal imaging. The proposed research will lead to a robust method for measuring FMD, suitable for routine clinical applications. Given the broad involvement of endothelial dysfunction in cardiovascular diseases and that ultrasound imaging is noninvasive and suitable for repeated examinations, the proposed research would have major implication in screening subjects for cardiovascular risks, diagnosing atherosclerosis and monitoring treatment responses.
描述(由申请人提供):内皮功能障碍是动脉粥样硬化的早期标志物,是一种重要的心血管危险因素,与许多疾病有关,包括高血压和糖尿病。因此,有一个主要的努力,以开发一种非侵入性的测试内皮功能障碍。通过超声成像测量的血流介导的肱动脉扩张提供了这种可能性,并且其用途已在各种临床研究中得到证实。尽管结果令人鼓舞,但不建议将该技术用于常规临床使用,主要是因为其灵敏度低且变异系数大。此应用程序旨在克服这些限制。我们建议使用复合成像,以提高图像质量;横截面成像,以提高灵敏度和变异系数,和自动边界检测连续监测血管舒张在超声检查。我们测试了这些概念是流动幻影,并表明灵敏度可以提高多达150倍,比传统的方法。我们还证明了该技术可用于对人类受试者进行成像。研究结果发表在最近的一篇文章中。在这项R21申请中,我们正在寻求对人类受试者可行性研究的支持。将在少量(N = 60)健康志愿者中测量血流介导的扩张。目的是证明使用复合和自动边界检测的肱动脉横截面超声成像比使用纵向成像的传统方法具有更高的灵敏度和可重复性。拟议的研究将导致一个强大的方法来测量FMD,适用于常规临床应用。鉴于内皮功能障碍在心血管疾病中的广泛参与,以及超声成像是非侵入性的且适合于重复检查,拟议的研究将在筛选受试者的心血管风险、诊断动脉粥样硬化和监测治疗反应方面具有重要意义。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Feed-forward active contour analysis for improved brachial artery reactivity testing.
用于改进肱动脉反应性测试的前馈活动轮廓分析。
- DOI:10.1177/1358863x16634194
- 发表时间:2016
- 期刊:
- 影响因子:0
- 作者:Pugliese,DanielN;Sehgal,ChandraM;Sultan,LaithR;Reamer,CourtneyB;Mohler3rd,EmileR
- 通讯作者:Mohler3rd,EmileR
On the modeling of mechanotransduction in flow-mediated dilation.
关于血流介导的扩张中的机械传导的建模。
- DOI:10.1016/j.jmbbm.2021.104606
- 发表时间:2021
- 期刊:
- 影响因子:3.9
- 作者:Sidnawi,Bchara;Chen,Zhen;Sehgal,Chandra;Santhanam,Sridhar;Wu,Qianhong
- 通讯作者:Wu,Qianhong
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHANDRA M SEHGAL其他文献
CHANDRA M SEHGAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHANDRA M SEHGAL', 18)}}的其他基金
Antivascular ultrasound therapy of primary liver neoplasia
原发性肝肿瘤的超声抗血管治疗
- 批准号:
9234984 - 财政年份:2017
- 资助金额:
$ 19.35万 - 项目类别:
Antivascular ultrasound therapy of primary liver neoplasia
原发性肝肿瘤的超声抗血管治疗
- 批准号:
10063483 - 财政年份:2017
- 资助金额:
$ 19.35万 - 项目类别:
Tunable microbubbles for antivascular ultrasound
用于抗血管超声的可调微泡
- 批准号:
9157676 - 财政年份:2016
- 资助金额:
$ 19.35万 - 项目类别:
Tunable microbubbles for antivascular ultrasound
用于抗血管超声的可调微泡
- 批准号:
9767166 - 财政年份:2016
- 资助金额:
$ 19.35万 - 项目类别:
Integrated photoacoustic and ultrasound imaging with the Vevo LAZR
使用 Vevo LAZR 集成光声和超声成像
- 批准号:
8640490 - 财政年份:2014
- 资助金额:
$ 19.35万 - 项目类别:
Quantitative diagnosis of breast cancer with ultrasound
乳腺癌的超声定量诊断
- 批准号:
7581824 - 财政年份:2008
- 资助金额:
$ 19.35万 - 项目类别:
Quantitative diagnosis of breast cancer with ultrasound
乳腺癌的超声定量诊断
- 批准号:
8387042 - 财政年份:2008
- 资助金额:
$ 19.35万 - 项目类别:
Quantitative diagnosis of breast cancer with ultrasound
乳腺癌的超声定量诊断
- 批准号:
8196858 - 财政年份:2008
- 资助金额:
$ 19.35万 - 项目类别:
Quantitative diagnosis of breast cancer with ultrasound
乳腺癌的超声定量诊断
- 批准号:
7742149 - 财政年份:2008
- 资助金额:
$ 19.35万 - 项目类别:
Quantitative diagnosis of breast cancer with ultrasound
乳腺癌的超声定量诊断
- 批准号:
7995228 - 财政年份:2008
- 资助金额:
$ 19.35万 - 项目类别:
相似国自然基金
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
- 批准号:91957111
- 批准年份:2019
- 资助金额:80.0 万元
- 项目类别:重大研究计划
高尿酸血症促进动脉粥样硬化机制探讨
- 批准号:81170251
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
- 批准号:81070247
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
- 批准号:81000086
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
- 批准号:30971216
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
- 批准号:30871040
- 批准年份:2008
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 19.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Contribution of Endothelial Planar Cell Polarity pathways in Blood Flow Direction Sensing
内皮平面细胞极性通路在血流方向传感中的贡献
- 批准号:
10750690 - 财政年份:2024
- 资助金额:
$ 19.35万 - 项目类别:
Colchicine for the prevention of vascular events after an acute intracerebral hemorrhage (CoVasc-ICH)
秋水仙碱用于预防急性脑出血后血管事件(CoVasc-ICH)
- 批准号:
485530 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
Operating Grants
Identifying the Role of Sex Hormones in Carotid Atherosclerotic Plaque Instability
确定性激素在颈动脉粥样硬化斑块不稳定中的作用
- 批准号:
494557 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
Operating Grants
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease
脂质的全基因组序列解释,以发现冠状动脉疾病的新基因和机制
- 批准号:
10722515 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:














{{item.name}}会员




